LET'S END

HEPC

Prevent. Treat. Cure. Together let’s END HepC!

Global Advisory board members:

Angelos Hatzakis, MD, PhD, MSc, is Professor of Epidemiology & Preventive Medicine and Director of the Department of Hygiene, Epidemiology & Medical Statistics at Athens University Medical School. He is also Head of the National Retrovirus Reference Center. He has been trained in Internal Medicine (“Hippokratio” General Hospital of Athens) and Epidemiology (Harvard School of Public Health). He has served in many Executive Committees including the presidency of the Hellenic CDC. He is Co-Chair and founder of Hepatitis B and C Public Policy Association. His research interests cover epidemiology, virology and prevention of viral diseases and oncogenic viruses. He is the author or coauthor of more than 200 scientific papers published in journals like Lancet, JAMA, Plos Medicine, British Medical Journal, Annals of Internal Medicine, Proceedings of the National Academy of Science/PNAS, AIDS, Journal of AIDS, Journal of Infectious Diseases, Hepatology, Gastroenterology, Antiviral Therapy, Blood, Cancer Research, Pediatrics etc.
Eberhard Schatz (1955) studied social work in Germany and worked for drug counselling services in Germany. 1990 - 1998 he worked for a service for foreign drug user in Amsterdam and developed cross- border cooperation projects between Germany and the Netherlands. From 1998 to 2004, he coordinated the European project AC Company, a network with 35 partner organisations, targeting mobile drug users in Europe. He is involved in different advisory boards at the national and international level. Since 2005, Mr Schatz has been one of the coordinators of Correlation – European Network Social Inclusion and Health, with more than 180 partners from all over Europe. He is responsible for the overall management of the project, the organisation of seminars and conferences (e.g. 'Social Inclusion and Health', Sofia, 2005; 'Out of the Margins', Ljubljana, 2011; Hepatitis C Community Summit, Amsterdam, 2017). He presents the network at many conferences and symposia and published numerous reports and articles. Currently, he is also coordinating the Correlation Hepatitis C initiative, which produced guidance documents for hepatitis c policy and practice and organised trainings, seminars and a HCV conference (2014, Berlin) and is he member of the Steering Committee of the European Harm Reduction Network. The Correlation Network is member of the Civil Society Forum on HIV/HCV and TB and the Civil Society Forum on Drugs. Mr Schatz was the chair of the CSF on Drugs between 2010 – 2013 and currently takes part in the coordination group of the CSF on HIV, HCV and TB.
Prof Jeffrey V. Lazarus is on the faculty at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona and at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He also serves as the Board Chair of AFEW International, a Board member of the EASL International Liver Foundation, a steering committee member of the HIV in Europe Initiative, the ACHIEVE Hepatitis Elimination coalition and of the European Commission’s joint action on HIV and hepatitis. He is a member of the BMC Editorial Advisory Group.
ELPA President and ACHIEVE Chair

Tatjana has been the President of European Liver Patients' Association (ELPA) since 2011. ELPA represents the collective voice of more than 100,000 people affected by liver disease. Established in 2005, it is an umbrella organization with 34 members in 27 countries involved in the fields of advocacy, scientific research and dissemination of information, aiming to highlight the heavy burden of liver disease in Europe. By raising awareness and by addressing the issue of prevention among healthcare professionals, policy-makers and the wider public ELPA is dedicated to promoting the interests of people with liver diseases across Europe and beyond. Prior to her tenure as President of the ELPA, back in the year 2000, she has founded “Hepatos”, the first hepatitis patient association in Croatia. Today “Hepatos” is a leading civil society organization that has played a crucial role in ensuring that viral hepatitis is recognized and put on the policy agenda as a social problem. In 2005 it became a member of ELPA where Tatjana took an active role as a member of the Steering and Advisory Committees, was the Vice President (2007 to 2011) before being elected the President in 2011. Tatjana is a doctor of veterinary medicine and holds an MSci from the University of Zagreb, Croatia. A member of the Board of Advisors for the Viral Hepatitis Prevention Board, member of WHO Hepatitis Civil Society Reference Group, member of Hepatitis Technical Advisory Group for Georgia’s Government Hepatitis C Elimination Program and several other expert organizations in the field of liver diseases well as a member of the Croatian National Committee for Viral Hepatitis and a founding member of the Croatian Alliance of Hepatitis Patients. Awarded, in 2010, by the Croatian Ministry of Health, the position of WHO focal point for Hepatitis she has held the position since then.

Local Advisory board members:

Centro Hospitalar Universitário de Coimbra
Hospital Pulido Valente
Licenciatura em Medicina em 1978, doutoramento em 1996, agregação em 2005, na Faculdade de Medicina da Universidade de Coimbra.
Professor catedrático, membro da Assembleia da Faculdade e regente da área de Medicina do 6º ano médico e Diretor da Clínica Universitária de Medicina Interna da FMUC.
Especialista em Medicina Interna, com dedicação especial à Hepatologia. Diretor do Serviço de Medicina Interna A do CHUC.
Participou em mais de 350 reuniões científicas nacionais e internacionais, como, presidente ou moderador. Autor ou coautor de mais de 450 comunicações científicas, sob a forma oral ou em poster, de 7 livros ou brochuras, 18 capítulos, 116 artigos científicos publicados por extenso e 19 publicações de índole didática ou de divulgação.
Vogal da Assembleia Geral da Sociedade Portuguesa de Medicina Interna. Académico correspondente da Academia Nacional de Medicina de Portugal. Presidente do Colégio de Medicina Interna da Ordem dos Médicos.
Centro Hospitalar Universitário de Coimbra
Associação SOS Hepatites
Licenciado pela Faculdade de Medicina da Universidade de Lisboa em 1981
Doutorado pela Faculdade de Medicina da Universidade de Lisboa em 2017
Director do Serviço de Doenças Infecciosas do Hospital de Curry Cabral - CHLC.
Chefe de Serviço de Medicina Interna.
Chefe de Serviço de Doenças Infecciosas.
Membro da equipa multidisciplinar do Grupo de Infertilidade Crónica e Procriação Medicamente Assistida da MAC.
Membro da equipa multidisciplinar do Centro Hepato-bilio-pancreático e de Transplantação do Hospital de Curry Cabral.
Presidente do Colégio da Especialidade de Doenças Infecciosas.
Presidente da Sociedade Portuguesa de Doenças Infecciosas.
Coordenador da Infecção por VIH/SIDA do Centro Hospitalar de Lisboa Central.
Professor Convidado da Faculdade de Medicina de Lisboa.
Membro do Conselho Consultivo do Programa Nacional para a Infecção por VIH/SIDA.
Membro do Grupo de Revisão do Programa Nacional de Luta Contra a Tuberculose da Direcção-Geral da Saúde.
Sócio efectivo da Sociedade Portuguesa de Doenças Infecciosas com vários cargos desempenhados nos seus órgãos sociais.
Sócio fundador da Associação Portuguesa para o Estudo Clínica da Sida (APECS) com vários cargos desempenhados nos seus órgãos sociais.
Sócio fundador da Sociedade Portuguesa de Hepatologia.
Sócio fundador da Sociedade Ibero-Americana de Infecciologia
Sócio fundador e membro do Grupo Português para o Estudo da Co-infecção VIH/VHB eVHC.
Hospital Santo António dos Capuchos
Director do Serviço de Gastrenterologia do Centro Hospitalar S. João, Porto
Professor da Faculdade de Medicina do Porto.
Membro do Governing Council da Organização Mundial de Gastrenterologia (WGO).
International Leadership Award do American College of Gastroenterology
Hospital de Santa Maria
Hospital de Egas Moniz
Concluiu os seus estudos em Bioquímica em 1983 na Universidade Pierre et Marie Curie, em Paris.
Foi diagnosticado como seropositivo para VIH e hepatite C em 1996.
É atualmente Presidente da Direção do GAT - Grupo de Ativistas em Tratamentos, ONG fundada em 2001 que trabalha na área do VIH, hepatites virais, tuberculose e política de drogas, tendo em vista a prevenção, diagnóstico precoce, tratamento e apoio a pessoas infetadas e afetadas por essas infeções.
É também fundador, e foi dirigente, da Associação Anti proibicionista (SOMA-APA).
É membro do EATG - European AIDS Treatment Group, grupo onde fez parte da direção. Representou Portugal no Fórum da Sociedade Civil sobre VIH/SIDA na Comissão Europeia.
Integra também o "Steering Committee" da iniciativa VIHPortugal.
Tem sido consultor comunitário do Gabinete Regional da Organização Mundial de Saúde para a Europa (WHO Europe), do Observatório Europeu da Droga e da Toxicodependência (EMCDDA), e do Centro Europeu de Prevenção e Controlo das Doenças(ECDC).
Foi nomeado “Comendador” pela Presidência da República em 2014, por serviços prestados à comunidade relativamente ao VIH e Hepatites Virais.
Pertence à direção da ACHIEVE Initiative e INSHU 2018.
Assistente Hospitalar Graduada de Gastrenterologia - CHLO, epe
Assistente da Nova Medical School (Faculdade de Ciências Médicas de Lisboa)
Professora auxiliar convidada do Instituto Egas Moniz de Ciências da Saúde
Artigos publicados em revistas nacionais e internacionais (>60) e capítulos de livros (16).
Apresentações sob forma de poster ou comunicação oral (>150)
Participação em Mesas redondas e conferências (>130)
Centro Hospitalar do Porto
MD, PhD, Associate Professor with Agregation, Medical School of Lisbon, Lisbon University, Portugal
Gastroenterology, Hepatology, Hospital S. Maria
Expert for the European Commission Programme Horizon 2020, 2016-2017
Elected Member of General Assembly of United European Gastroenterology-UEG (2014-2017)
Selected for “Visiting Fellowships for Clinicians”, UEG, 2017 and 2018, Mentoring Programme, UEG 2017
Vice-President (2013-2019), General-Secretary (2005-2007) of Portuguese Society of Gastroenterology
President of Digestive Week 2017
President of Portuguese Board of Hepatology (2013-2015)
President (2007-2009) and General-Secretary (1993-1997) of Portuguese Association for the Study of The Liver
Adviser of Viral Hepatitis Prevention Board, www.vhpb.org, since 2008.
Fellow of European Board of Gastroenterology and Hepatology (FEBGH), since 2009.
Editor-in-Chief of Acta Médica Portuguesa, Scientific Journal of Portuguese Medical Association (2011-2016), IF, Thomson-Reuters, Editor-in-Chief of Portuguese Journal of Gastroenterology (2009-2011), PubMed
Coordenator of the advisory group of INFARMED for HCV therapy (2014-2015)
Member of Pedagogic Committee of Medical School of Lisbon, Scientific Board of Masters in Palliative Care, Group for Reformation of Clinical Years, Medical School of Lisbon
Medal of Merit of Portuguese Medical Association, 2015
85 papers in PubMed inc. NEJM, Gastroenterology, Liver International, Journal Viral Hepatitis, Annals Oncology, Lancet Gastr Hepatol, World J Gastroenterol, Endoscopy, etc
Organizer of 24 meetings including the Digestive Week (National Congress of Gastroenterology) 2017 and International Network Hepatitis in Substance Users, Portugal, 2018
Prof. Dr. Markus Peck-Radosavljevic worked for the university hospital in Vienna up until 2 years ago and ever since then became head of the department of internal medicine and gastroenterology in Klagenfurt. He published a variety of important papers in different subareas of hepatology. In addition to that he was the general secretary for the EASL (Europeans Association for the Study of the Liver), which is the leading medical societies for hepatology, for two years. In that function he gained an extensive inside into the epidemiologic data for Hepatitis C, not only for Austria but all of Europe.
Zoller is one of the leading hepatologist in western Austria and is currently working at the university hospital in Innsbruck. He specialized in genetic liver diseases and has a substantial interest in the epidemiology of Hepatitis C. He recently published a very important paper in which he described the epidemiologic data for Hepatitis C in Tyrol, his home state, and how he can project the prevalence for the next decades based on this very finding.
Prof. Dr. Thomas Reiberger is a hepatologist at the university hospital in Vienna and currently leading the specialized clinic for advanced liver diseases. His fields of interest are liver cirrhosis and portal hypertension. In the last couple of years Hepatitis C, its prevalence and therapy, also shifted into his field of research. At the moment he mainly focuses on imprisoned Hepatitis C patients and therefore became an important hepatology consultant at many Austrian prisons.
Dr. Daniela Schmid is working for the AGES (Österreichische Agentur für Gesundheit und Ernährungssicherheit) where her focus is Hepatitis C. Since Hepatitis C is a disease which is subject to registration in Austria and all these reports converge in her office, she has the ideal overview concerning the epidemiology of Hepatitis C in Austria and its development over the years.
Prof. Dr. Peter Ferenci is one of the leading hepatologist in Austria. His main fields of interest lie in M. Wilson and Hepatitis C. He has published a great amount of hallmark papers concerning the treatment of Hepatitis C, one of which was published in the The New England Journal of Medicine. Other of his important papers dealt with the blood transfusion transmission and vertical transmission of Hepatitis C.
Dr. Hans Haltmayer is the director of the Suchthilfe Wien and has been for the past 7 years. This outpatient clinic is the most important places to support people who inject drugs in Vienna. It’s a low-threshold institution which integrated sufficient support and care for Hepatitis C patients since it offers night shelters and a health center working psychiatrists, hepatologist, addiction specialists and many more.
Prof. Dr. Michael Gschwantler is leading the gastroenterology and hepatology department at the Wilhelminenspital in Vienna. His main fields of research for the last seven years include the epidemiology and different therapies of Hepatitis C and their development. Together with Dr. Hans Haltmayer he introduced of a new concept (directly observed therapy), where people who inject drugs can visit a low-threshold facility or pharmacy daily for ingestion of their opioid substitution therapy plus their Hepatitis C treatment under supervision of a physician or nurse.
Maria Buti earned her medical degree at the University of Barcelona and her PhD in Internal Medicine at the University “Autónoma” de Barcelona, Spain. She is currently Professor of Medicine and Chief of Internal Medicine and Hepatology at the Hospital General Universitari Valle Hebron, Barcelona. Dr Butí has worked in viral hepatitis for the last 25 years, particularly in diagnosis and therapy of hepatitis B and C. She has been published widely in the field of liver disease, with numerous papers and contributions to books Dr Butí is the President of the Spanish Association for the Study of Liver Diseases, and an active member of the EASL, and the AASLD and various professional societies.
Co-ordinator, Alliance for the Elimination of Viral Hepatitis in Spain (Alianza para la Eliminación de las Hepatitis Víricas en España, AEHVE), and head of liver unit, Hospital Universitario La Paz, Madrid
Universidad de Cantabria Department of Medicine and PsychiatrySantander, Cantabria, Spain Professor Hospital Universitario Marques de Valdecilla Servicio de DigestivoSantander, Spain Position Head of Gastroenterology and Hepatology Department
Specialist in Gastroenterology and Hepatology since 1995 Assistant Chief of the Department of Gastroenterology and Hepatology . Hospital Universitario Puerta de Hierro. Madrid ACADEMIC EXPERIENCE - Medical Degree (1990). Universidad Autónoma de Madrid - Ph D: Doctoral Thesis: Non invasive evaluation of the portal flor and forearm flor to predict the portal presure response to pharmacological treatment” 1997. SPECIAL NATIONAL AWARD - Associate Proffesor of Medicine – Universidad Autonoma de Madrid since 2003-2011 - Professor of Medicine . Universidad Autonoma de Madrid since 2011
From Barcelona, hepatologist, studied Medicine at the University of Barcelona and carried out her speciality in the Hospital Universitary Bellvitge (1975-1980). She worked as a consultant specialist in viral hepatitis and transplant (liver and kidney) at the same hospital until 2016, collaborating in multidisciplinary teams (viral hepatitis and transplants). She received her Ph D in 1994 in the University of Barcelona, with a study about History of Medicine considering the development of the speciality of gastroenterology and hepatology in Catalonia (1871-1921).
She lead phase II and III clinical trials of anti viral drugs studies (1998-2014). She received research grants for studies on health related quality of life (HRQOL) in liver patients (pre and post transplant, translation and validation of a specific test). Clinical research on hepatitis C virus and transplant( liver / kidney) and Prevention protocols oh HBV after liver transplant. Epidemiological studies on the HBsAg carriers detected when they were blood donors. In 2008 studied a master course on DISS (Direcció Integrada de Programes de Salut) in the ESADE school of bussiness in Barcelona. For the period 2008-2012 she was the responsable for the Program of Viral Hepatitis for the Bellvitge Hospital and its geographical área.
Since her retirement in 2016 she is collaborating as a president of the ASSCAT (Asociació Catalana de Malalts d’ Hepatitis) which aim is to educate, inform and support patients and families about liver diseases. ASSCAT belongs to ELPA, to WHA (World Hepatitis Alliance) and to AEHVE (Alianza para la eliminación de las hepatitis víricas en España). She is a member of the Board and the Scientific Committee of ELPA
General director of the Programme on Substance Abuse of the Public Health Agency
Managing director, Consorcio Hospital General Universitario, Valencia
President, National Federation of Liver Patients and Transplants (Federación Nacional de Enfermos y Trasplantados Hepáticos), Madrid
Full Professor of Medicine, Faculty of Medicine at the University of Malaga and Director of the Service of Gastroenterology and Hepatology, University Hospital of Málaga (Spain). He is also the director of the Spanish DILI Registry network (www.spanishdili.uma.es) and of the Spanish Latin-American DILI Network (www.slatindili.uma.es).
Editor de Gaceta Médica, El Global y EDS-Economía de la Salud
Head of service, department of digestive diseases, University Hospital Complex, Pontevedra
Professor of Medicine in the University of Seville, Spain. Head of the Mac.Ro Digestive Diseases Department at Virgen del Rocío University Hospitals. Head of group for translational research in liver diseases (SeLiver) at Institute of Biomedicine of Seville (IBIS). Coordinator of the Spanish Registry of NAFLD/NASH (HepaMET) and co-coordinator of the EASL supported European Registry of NAFLD. Principal Investigator of the group for research in Viral Hepatitis area in the Spanish Network for Research in Digestive and liver diseases (CiberEHD). Prof Romero-Gómez received the XI Award Javier Benjumea Puigcerver in investigation, Universidad de Sevilla-Focus Abengoa, 2014. He was awarded with the Medal of The City of Seville in 2016. He has published more than 300 peer-reviewed papers on gastrointestinal and liver diseases. He has protected 10 patents and participated as PI in more than 20 competitive grants for research.
Member of the governing boards of the Bulgarian Association for the Study of the Liver and the Bulgarian Association of Gastroenterology, Gastrointestinal Endoscopy and Ultrasound
Gastroenterology expert to the National Health Insurance Found
Chief Expert, Directorate “Drug products, medical devises and control in prescription and release”
National Health Insurance Found
Secretary of the Bulgarian Association of Gastroenterology, Gastrointestinal Endoscopy and Ultrasound
Vice-Secretary and Treasurer of the Bulgarian Association for the Study of the Liver and the Bulgarian Association of Gastroenterology, Gastrointestinal Endoscopy and Ultrasound
Gastroenterology expert to the National Health Insurance Found
National Centre for Public Health and Analysis, Ministry of Health.
Director of Directorate “National health data and e-health”.
President of the Bulgarian Association of Gastroenterology, Gastrointestinal Endoscopy and Ultrasound
Member of the governing board of the Bulgarian Association for the Study of the Liver
National consultant in Gastroenterology
Gastroenterology expert to the National Health Insurance Found
Head of Clinic of Gastroenterology, Head of the Department of Gastroenterology, Hepato-biliary, pancreatic surgery and transplantology, Military Medical Academy
President of the Bulgarian Association for the Study of the Liver
Member of the governing board of the Bulgarian Society of Gastroenterology, Gastrointestinal Еndoscopy and Ultrasound
Gastroenterology expert to the National Health Insurance Found
Head of Clinic of Gastroenterology and Expert Center of Rare Diseases: Hereditary Metabolic Liver Diseases, University Hospital St. Ivan Rilski, Sofia
Professor of gastroenterology and internal medicine at Chair of  Internal Medicine, Faculty of Medicine, Medical University- Sofia 
Member of the governing board of the Bulgarian Association for the Study of the Liver.
Lead working group “Treatment of viral hepatitis in addicted patients” in Bulgarian Association for the Study of the Liver
President of HepActive patient association
HepActive patient association
Chairperson of National Association for Fighting Hepatitis ‘Hepasist’
Secretary General of European Accession Partnership on Health
Director, Programmes financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria
Ministry of Health
Gastroenterology and Hepatology-Deputy MoH.
Head of the public Health Department - University.
Gastroenterology and Helatology - University.
President APAH-RO, Board member of ELPA.
President, COPAC, the largest PAG’s coalition in Romania.
Infectious Diseases- University.

“Hepatitis C is found worldwide. The most affected regions are Africa and Central and East Asia. Depending on the country, hepatitis C infection can be concentrated in certain populations”

in WHO Fact sheet N°164
Updated July 2015